436 related articles for article (PubMed ID: 30712903)
1. Comprehensive Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Profiles in Reproductive-Age Women with Polycystic Ovary Syndrome: A Large Canadian Cohort.
Kazemi M; Pierson RA; Lujan ME; Chilibeck PD; McBreairty LE; Gordon JJ; Serrao SB; Zello GA; Chizen DR
J Obstet Gynaecol Can; 2019 Oct; 41(10):1453-1460. PubMed ID: 30712903
[TBL] [Abstract][Full Text] [Related]
2. Glucose intolerance in a large cohort of mediterranean women with polycystic ovary syndrome: phenotype and associated factors.
Gambineri A; Pelusi C; Manicardi E; Vicennati V; Cacciari M; Morselli-Labate AM; Pagotto U; Pasquali R
Diabetes; 2004 Sep; 53(9):2353-8. PubMed ID: 15331545
[TBL] [Abstract][Full Text] [Related]
3. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
[TBL] [Abstract][Full Text] [Related]
4. The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment.
Pasquali R; Gambineri A; Anconetani B; Vicennati V; Colitta D; Caramelli E; Casimirri F; Morselli-Labate AM
Clin Endocrinol (Oxf); 1999 Apr; 50(4):517-27. PubMed ID: 10468913
[TBL] [Abstract][Full Text] [Related]
5. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
Li X; Lin JF
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.
Legro RS; Kunselman AR; Dodson WC; Dunaif A
J Clin Endocrinol Metab; 1999 Jan; 84(1):165-9. PubMed ID: 9920077
[TBL] [Abstract][Full Text] [Related]
7. [Exploration of the classification of polycystic ovarian syndrome].
Lin JF; Li X; Zhu MW
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome.
Apridonidze T; Essah PA; Iuorno MJ; Nestler JE
J Clin Endocrinol Metab; 2005 Apr; 90(4):1929-35. PubMed ID: 15623819
[TBL] [Abstract][Full Text] [Related]
9. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C
Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
[TBL] [Abstract][Full Text] [Related]
10. Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries.
Robinson S; Henderson AD; Gelding SV; Kiddy D; Niththyananthan R; Bush A; Richmond W; Johnston DG; Franks S
Clin Endocrinol (Oxf); 1996 Mar; 44(3):277-84. PubMed ID: 8729522
[TBL] [Abstract][Full Text] [Related]
11. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.
Diamanti-Kandarakis E; Kouli CR; Bergiele AT; Filandra FA; Tsianateli TC; Spina GG; Zapanti ED; Bartzis MI
J Clin Endocrinol Metab; 1999 Nov; 84(11):4006-11. PubMed ID: 10566641
[TBL] [Abstract][Full Text] [Related]
12. Metabolic approaches to the subclassification of polycystic ovary syndrome.
Norman RJ; Masters SC; Hague W; Beng C; Pannall P; Wang JX
Fertil Steril; 1995 Feb; 63(2):329-35. PubMed ID: 7843439
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome.
Soares EM; Azevedo GD; Gadelha RG; Lemos TM; Maranhão TM
Fertil Steril; 2008 Mar; 89(3):649-55. PubMed ID: 17543961
[TBL] [Abstract][Full Text] [Related]
14. Using metabolic markers to identify insulin resistance in premenopausal women with and without polycystic ovary syndrome.
Blum MR; Popat RA; Nagy A; Cataldo NA; McLaughlin TL
J Endocrinol Invest; 2021 Oct; 44(10):2123-2130. PubMed ID: 33687700
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of polycystic ovarian changes and polycystic ovary syndrome in premenopausal women with treated type 2 diabetes mellitus.
Kelestimur F; Unluhizarci K; Baybuga H; Atmaca H; Bayram F; Sahin Y
Fertil Steril; 2006 Aug; 86(2):405-10. PubMed ID: 16762349
[TBL] [Abstract][Full Text] [Related]
16. Elevated serum levels of interleukin-18 are associated with insulin resistance in women with polycystic ovary syndrome.
Zhang YF; Yang YS; Hong J; Gu WQ; Shen CF; Xu M; Du PF; Li XY; Ning G
Endocrine; 2006 Jun; 29(3):419-23. PubMed ID: 16943580
[TBL] [Abstract][Full Text] [Related]
17. Oxidised low-density lipoprotein concentration - early marker of an altered lipid metabolism in young women with PCOS.
Macut D; Damjanovic S; Panidis D; Spanos N; Glisic B; Petakov M; Rousso D; Kourtis A; Bjekic J; Milic N
Eur J Endocrinol; 2006 Jul; 155(1):131-6. PubMed ID: 16793959
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of insulin resistance and prediction of glucose intolerance and type 2 diabetes mellitus in women with polycystic ovary syndrome.
Vrbikova J; Dvorakova K; Grimmichova T; Hill M; Stanicka S; Cibula D; Bendlova B; Starka L; Vondra K
Clin Chem Lab Med; 2007; 45(5):639-44. PubMed ID: 17484627
[TBL] [Abstract][Full Text] [Related]
19. Acanthosis nigricans: clinical predictor of abnormal glucose tolerance in Asian women with polycystic ovary syndrome.
Charnvises K; Weerakiet S; Tingthanatikul Y; Wansumrith S; Chanprasertyothin S; Rojanasakul A
Gynecol Endocrinol; 2005 Sep; 21(3):161-4. PubMed ID: 16335908
[TBL] [Abstract][Full Text] [Related]
20. Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome.
Falsetti L; Pasinetti E
Acta Obstet Gynecol Scand; 1995 Jan; 74(1):56-60. PubMed ID: 7856434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
